Researches

Displaying 31 - 40 of 4031
# Title Department Research Year
31 CDK2 Inhibitors: Rationally Directed Discovery of a Novel Potent Lead derived from Cyclohepta[e]thieno[2,3-b]pyridine Department of Pharmaceutical Organic Chemistry 2025
32 Clinical significance of interleukin 10, interleukin 33, and interleukin 35 on induction chemotherapy in acute myeloid leukemia patients Department of Microbiology and Immunology 2025
33 Cobalt-induced oxidative stress and defense responses of Adhatoda vasica proliferated shoots Department of Pharmacognosy 2025
34 Comparative study of different treatment modalities for melasma: introducing a novel nanotechnology-based tranexamic acid microemulsion Department of Industrial Pharmacy 2025
35 Copper-chelation-induced ratiometric fluorescence response for sensitive ratiometric detection of zoledronic acid: implications for monitoring in renal impairment Department of Pharmaceutical Analytical Chemistry 2025
36 Crystal structure and quantum chemical calculations of 2-(2'-oxospiro[1,3-dioxolane-2,3'-indol]-1'(2'H)-yl)acetohydrazide Department of Medicinal Chemistry 2025
37 Design and synthesis of 5-substituted-2-Iminothiazolidin-4-one Derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa virulence factors: An integrated study of molecular docking, dynamics, and biological assays Department of Medicinal Chemistry 2025
38 Design, synthesis, and antiproliferative activity of new 2-amino-pyrano[3,2-c]quinoline-3- carbonitriles as potential EGFR, BRAFV600E, and HER-2 inhibitors Department of Pharmaceutical Organic Chemistry 2025
39 Design, synthesis, and antiproliferative activity of new 5-ethylsulfonylindazole- 3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors Department of Pharmaceutical Organic Chemistry 2025
40 Design, Synthesis, and Antiproliferative Activity of Novel Indole/1,2,4-Triazole Hybrids as Tubulin Polymerization Inhibitors Department of Pharmaceutical Organic Chemistry 2025